RHY
RHYTHM BIO FPO [RHY]
Healthcare · ASX Small Cap
$0.2100 -2.3%
Updated 2026-03-02 · Scores refresh every scan
Appeared in 2 consecutive scans→ Score +5First seen: 2026-02-25
Score Breakdown
Technical55
Catalyst51
Sentiment50
Fundamental25
Momentum66
Risk Gate50
Active Signals
Bullish Signals
- Bollinger squeeze (breakout building)
- Volatility contracting (breakout setup)
- Above 200-day MA (long-term uptrend)
- Critical cash runway (1.1 quarters)
- Revenue in sharp decline (-49%)
- Small-cap ($20-100M)
- Capital raise activity (1 events)
- CANSLIM I: Institutional ownership (11%)
- Strong 12-1 momentum (+217%)
- Excellent risk-adjusted momentum (Sharpe 1.8)
- ASX200 bullish (+1.5% 5d)
- RBA cutting (+2pts)
Risk Signals
- MACD momentum weakening
- Piotroski F-Score weak (3/9)
- Insufficient sentiment data (defaulting to neutral)
- Neutral/mixed sentiment
- Revenue momentum declining (-49%)
Recent Catalysts
NONE Cleansing Notice
NONE Application for quotation of securities - RHY
NONE Application for quotation of securities - RHY
Recent ASX Announcements
| 2026-02-27 | Cleansing Notice |
| 2026-02-27 | Application for quotation of securities - RHY |
| 2026-02-26 | Application for quotation of securities - RHY |
| 2026-02-26 | $5.5 million Secured for RHYO Options |
| 2026-02-25 | NHS England ColoSTAT Evaluation Commences |
Key Metrics
$70.4M
Market Cap
1.3M
Avg Volume
0.6x
Vol Ratio
$0.05 — $0.28
52-Week Range
N/A
Short Interest
N/A
Cash Runway
-190.1%
ROE
N/A
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | neutral | Float: 72% |
| L | Leader vs Laggard | pass | RS: 33 |
| I | Institutional Sponsorship | pass | Inst: 11% |
| M | Market Direction | pass | Bullish |
Sector: Healthcare
Ranked #108 of 119 · Sector avg: 51
View all Healthcare signals →